Charles Schwab Investment Management Inc. decreased its holdings in shares of Owens & Minor, Inc. (NYSE:OMI) by 3.2% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 698,486 shares of the company’s stock after selling 22,908 shares during the period. Charles Schwab Investment Management Inc. owned approximately 0.95% of Owens & Minor worth $18,895,000 at the end of the most recent quarter.
Other hedge funds have also modified their holdings of the company. Graves Light Private Wealth Management Inc. purchased a new stake in shares of Owens & Minor during the fourth quarter worth about $25,000. Perigon Wealth Management LLC purchased a new stake in shares of Owens & Minor during the fourth quarter worth about $54,000. First Trust Advisors LP acquired a new stake in shares of Owens & Minor during the first quarter worth about $56,000. Veriti Management LLC acquired a new stake in shares of Owens & Minor during the fourth quarter worth about $72,000. Finally, Canal Capital Management LLC acquired a new stake in shares of Owens & Minor during the fourth quarter worth about $205,000. Institutional investors and hedge funds own 72.98% of the company’s stock.
Shares of OMI stock opened at $37.42 on Thursday. The company has a debt-to-equity ratio of 2.44, a current ratio of 1.47 and a quick ratio of 0.70. The company has a market cap of $2.75 billion, a price-to-earnings ratio of -37.80, a PEG ratio of 0.24 and a beta of 0.26. The stock has a 50 day simple moving average of $34.31 and a 200-day simple moving average of $28.16. Owens & Minor, Inc. has a 1-year low of $5.50 and a 1-year high of $39.45.
The firm also recently announced a quarterly dividend, which was paid on Wednesday, March 31st. Stockholders of record on Monday, March 15th were paid a dividend of $0.002 per share. This represents a $0.01 annualized dividend and a dividend yield of 0.02%. The ex-dividend date of this dividend was Friday, March 12th. Owens & Minor’s payout ratio is 1.79%.
In other news, Director Robert J. Henkel purchased 1,000 shares of the company’s stock in a transaction that occurred on Friday, January 15th. The stock was purchased at an average cost of $27.11 per share, for a total transaction of $27,110.00. Following the completion of the transaction, the director now owns 21,000 shares of the company’s stock, valued at $569,310. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Shana Carol Neal sold 4,791 shares of the business’s stock in a transaction that occurred on Tuesday, February 16th. The stock was sold at an average price of $27.54, for a total value of $131,944.14. Following the sale, the insider now owns 161,028 shares of the company’s stock, valued at $4,434,711.12. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 55,447 shares of company stock valued at $1,984,139. Corporate insiders own 2.15% of the company’s stock.
A number of research firms recently commented on OMI. Smith Barney Citigroup began coverage on Owens & Minor in a report on Friday, December 11th. They set a “neutral” rating and a $30.00 target price for the company. UBS Group raised Owens & Minor from a “neutral” rating to a “buy” rating and lifted their target price for the stock from $27.00 to $37.00 in a report on Thursday, December 17th. Robert W. Baird raised Owens & Minor to an “outperform” rating and boosted their price target for the company from $45.00 to $50.00 in a report on Friday, March 26th. Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell began coverage on Owens & Minor in a report on Friday, December 11th. They issued a “neutral” rating and a $30.00 price target for the company. Finally, Barclays boosted their price target on Owens & Minor from $23.00 to $33.00 and gave the company an “equal weight” rating in a report on Thursday, February 25th. Five investment analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the company. The company has a consensus rating of “Buy” and a consensus target price of $28.45.
Owens & Minor Profile
Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally. It operates through two segments, Global Solutions and Global Products. The Global Solutions segment offers a portfolio of products and services to healthcare providers and manufacturers.
Featured Article: Find a Trading Strategy That Works
Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.